🧪
hypothesis

Synthetic Biology Approach: Designer Mitochondrial Export Systems

Hypothesis

Synthetic Biology Approach: Designer Mitochondrial Export Systems

Engineering synthetic organelle export machinery combining elements from bacterial secretion systems with mammalian mitochondrial targeting sequences creates enhanced mitochondrial transfer capabilities.
🧬 Synthetic fusion proteins🩺 neurodegeneration🎯 Composite 50%💱 $0.51▼23.4%proposed
🟡 ALS / Motor Neuron Disease🔴 Alzheimer's Disease🔥 Neuroinflammation🟢 Parkinson's Disease
EvidencePending (0%)📖 23 cit🗣 3 debates 3 support 3 oppose
✓ All Quality Gates Passed
Mechanistic 0.30 (15%) Evidence 0.20 (15%) Novelty 0.90 (12%) Feasibility 0.20 (12%) Impact 0.80 (12%) Druggability 0.10 (10%) Safety 0.20 (8%) Competition 0.90 (6%) Data Avail. 0.20 (5%) Reproducible 0.20 (5%) KG Connect 0.36 (8%) 0.505 composite
🏆 ChallengeSolve: APOE4 structural biology and therapeutic targeting strategies$184K →
☰ Compare⚔️ Duel⚛️ Collide
📄 Export LaTeX
arXiv PreprintNeurIPSNature MethodsPLOS ONE
📖 Export BibTeXinteract with this hypothesis
Composite50%

🧪 Overview

Engineering synthetic organelle export machinery combining elements from bacterial secretion systems with mammalian mitochondrial targeting sequences creates enhanced mitochondrial transfer capabilities.

🧬 Mechanism

🧬 Curated Mechanism Pathway

Curated pathway from expert analysis

graph TD
    A["Synthetic Fusion<br/>Proteins"] --> B["Mitochondrial<br/>Targeting Signals"]
    A --> C["Cell Surface<br/>Export Domains"]
    B --> D["Healthy Donor<br/>Mitochondria"]
    C --> E["Extracellular<br/>Vesicle Formation"]
    D --> F["Enhanced Mitochondrial<br/>Packaging"]
    E --> G["Targeted Vesicle<br/>Release"]
    F --> G
    G --> H["Recipient Neuron<br/>Uptake"]
    H --> I["Mitochondrial<br/>Integration"]
    I --> J["Restored ATP<br/>Production"]
    I --> K["Improved Ca2+<br/>Homeostasis"]
    I --> L["Reduced ROS<br/>Generation"]
    J --> M["Neuronal Function<br/>Recovery"]
    K --> M
    L --> M
    N["Neurodegeneration<br/>Pathology"] --> O["Mitochondrial<br/>Dysfunction"]
    O --> P["Therapeutic<br/>Intervention"]
    P --> M

    classDef normal fill:#4fc3f7,color:#0d0d1a
    classDef therapeutic fill:#81c784,color:#0d0d1a
    classDef pathology fill:#ef5350,color:#0d0d1a
    classDef outcome fill:#ffd54f,color:#0d0d1a
    classDef molecular fill:#ce93d8,color:#0d0d1a

    class D,H,I,J,K,L normal
    class A,E,F,G,P therapeutic
    class N,O pathology
    class M outcome
    class B,C molecular

⚖️ Evidence

⚖️ Evidence Matrix3 supports3 contradicts
Supports
Bacterial secretion systems can be adapted for eukaryotic organelle transport
PMID:32273439
Supports
Synthetic mitochondrial targeting sequences enhance organelle delivery
PMID:31285632
Supports
Engineered cell-to-cell transfer systems show therapeutic potential
PMID:33846704
Contradicts
Bacterial Type VI secretion systems require complex machinery incompatible with eukaryotic cells
PMID:32847293
Contradicts
Previous attempts to engineer organelle export systems have shown limited success and significant toxicity
PMID:33156741
Contradicts
Mitochondrial targeting sequences often mislocalize synthetic proteins, causing cellular dysfunction
PMID:31947382
📖 Linked Papers (19)Export BibTeX ↗
Harlequin syndrome associated with thoracic epidural anaesthesia.
Anaesthesia reports (2022) · PubMed:35118419 ↗
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
Transmission dynamics of a linear vanA-plasmid during a nosocomial multiclonal outbreak of vancomycin-resistant enterococci in a non-endemic area, Japan.
Scientific reports (2021) · PubMed:34285270 ↗
8 figures
Figure 1
Figure 1
Minimum inhibitory concentration of vancomycin and teicoplanin for vancomycin-resistant Enterococcus faecium isolates during the outbreak. According to the cr...
Figure 2
Figure 2
Dendrogram of pulsotypes in pulsed-field gel electrophoresis and sequence types in multilocus sequence typing among vancomycin-resistant Enterococcus faecium ...
High resolution spatiotemporal patterns of seawater temperatures across the Belize Mesoamerican Barrier Reef.
Scientific data (2020) · PubMed:33199700 ↗
3 figures
Fig. 1
Fig. 1
Map of logger deployment sites in Belize.
Fig. 2
Fig. 2
Cross-sectional view of Carrie Bow Caye describing back reef and the two fore reefs in this area: inner fore reef and outer fore reef.
Lipid rafts: structure, function and role in HIV, Alzheimer's and prion diseases.
Expert reviews in molecular medicine (2002) · PubMed:14987385 ↗
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
Transgenic modelling of neurodegenerative events gathers momentum
Trends in Neurosciences (1991) · PubMed:1726340 ↗
1 figure
Figures
Figures
Figures available at source paper (no open-access XML found).
Optimized bacterial expression of a synthetic BRIL antibody.
Acta Crystallogr F Struct Biol Commun (2026) · PubMed:41842660 ↗
No figures
Design and synthesis of BAP-1 inhibitors.
Pak J Pharm Sci (2026) · PubMed:41761813 ↗
No figures
MTAP Deletion in Oncogenesis: A Synthetic Lethality Scenario.
Cancer Res (2026) · PubMed:41512197 ↗
No figures
Engineering chimeric signaling proteins for microbial whole-cell biosensors: from design to deployment.
Trends Biotechnol (2026) · PubMed:40903364 ↗
No figures
Integrating biocatalysis with continuous flow: current status, challenges, and future perspectives.
J Adv Res (2026) · PubMed:40639553 ↗
No figures
ZLN005 Alleviates the Dopaminergic Degeneration via PGC-1α-Mediated Mitochondrial Homeostasis in Parkinson's Disease.
Molecular neurobiology (2025) · PubMed:41400900 ↗
No figures
Bacterial DNA methylases as novel molecular and synthetic biology tools: recent developments.
Applied microbiology and biotechnology (2025) · PubMed:40047928 ↗
No figures
📙 Related Wiki Pages (15)
Section 132: Advanced Systems ImmunologytherapeuticMitochondrial Biogenesis InducerstherapeuticMitochondrial Support Strategies for CBStherapeuticSection 135: Telomere Biology and Anti-AtherapeuticMitochondrial TherapeuticstherapeuticMitochondrial Dynamics Modulators for NetherapeuticMitochondrial Fusion in NeurodegeneratiomechanismSynthetic Gene Circuit for Feedback-ContideaSynthetic Lethality and PARP Inhibition mechanismExPlas — Exercise Plasma Transfusion forclinicalND0612 Subcutaneous Levodopa Infusion PDclinicalAD Targeted Protein Degradation and SyntcompanyAD Synthetic Biology CompaniescompanyMitochondrial Dynamics Pathway: Fusion amechanismDipeptide Repeat Proteins (DPRs) in C9ormechanism

🏥 Translation

🧬 3D Protein Structure — SYNTHETIC

No curated PDB or AlphaFold mapping for SYNTHETIC yet. Search RCSB →

💉 Clinical Trials (5)Relevance: 38%

0
Active
0
Completed
1,240
Total Enrolled
PHASE1
Highest Phase
Neuroinflammation and Neurodegeneration in HIV-positive Subjects Switched and Initially Treated With INSTINA
UNKNOWN·NCT04887675 · University of Novi Sad
120 enrolled · 2021-05-01 · → 2022-06-01
Since the HIV changed its course to the chronic disease, high incidence of metabolic syndrome both in HIV positive and negative subjects has become an issue. Given the successful peripheral suppressio
HIV I Infection HIV Associated Lipodystrophy Metabolic Syndrome
MRI
An Innovative Method in SAliva Samples for the Early Differential Diagnosis of High-impact NeuroDegenerative Diseases Through Raman SpectroscopyUnknown
ENROLLING_BY_INVITATION·NCT06875739 · Fondazione Don Carlo Gnocchi Onlus
310 enrolled · 2025-02-14 · → 2026-10-01
The aim of the study is to validate a salivary test that allows for rapid and accurate objective diagnosis in the context of neurodegenerative diseases, a complex of diseases that includes Alzheimer's
Neurodegenerative Disorders Parkinson Disease Alzheimer Disease
Natural History of Glycosphingolipid Storage Disorders and Glycoprotein DisordersUnknown
RECRUITING·NCT00029965 · National Human Genome Research Institute (NHGRI)
200 enrolled · 2002-02-06
Study description: This is a natural history study that will evaluate any patient with enzyme or DNA confirmed GM1 or GM2 gangliosidosis, sialidosis or galactosialidosis. Patients may be evaluated ev
Neurological Regression Myoclonus Cherry Red Spot
Retinal and Cognitive Dysfunction in Type 2 DiabetesUnknown
COMPLETED·NCT04281186 · Hospital Universitari Vall d'Hebron Research Institute
510 enrolled · 2020-11-16 · → 2024-12-12
The retina shares similar embryologic origin, anatomical features and physiological properties with the brain and hence offers a unique and accessible "window" to study the correlates and consequences
Retinal Function Cognitive Dysfunction Microperimetry
A Noval Tau Tracer in Young Onset DementiaPHASE1
UNKNOWN·NCT04248270 · Chang Gung Memorial Hospital
100 enrolled · 2020-02-20 · → 2023-08-17
Dementia is a clinical syndrome which characterized by progressive cognitive impairment, behavior disturbance and dysfunction of daily activity. In aging population, Alzheimer's dementia (AD) is the m
Alzheimer's Disease Vascular Dementia Dementia
18F-PM-PBB3

No curated ClinVar variants loaded for this hypothesis.

Run scripts/backfill_clinvar_variants.py to fetch P/LP/VUS variants.

🔍 Search ClinVar for Synthetic fusion proteins →

No DepMap CRISPR Chronos data found for Synthetic fusion proteins.

Run python3 scripts/backfill_hypothesis_depmap.py to populate.

💰 Estimated Development
Cost
$0
Timeline
3.5 years

🏆 Tournament

🏆 Arenas / Elo

No arena matches recorded yet. Browse Arenas →

📊 Market Indicators

7d Trend
Stable
7d Momentum
▼ 0.7%
Volatility
Low
0.0090
Events (7d)
6
Price History
▼23.4%

💾 Resource Usage

LLM Tokens
39,356
$0.2361
Total Cost
$0.2361

🔮 Predictions

🔎 Predictions vs Observations5 predictions · 0 with recorded observations
PredictionPredictedObservedStatusConf
If hypothesis is true, intervention be re-engineered to function in the mammalian cellular environmentbe re-engineered to function in the mammalian cellular environment— no observation —pending0.20
If hypothesis is true, intervention require a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniquesrequire a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniques— no observation —pending0.20
If hypothesis is true, intervention require extensive optimizationrequire extensive optimization— no observation —pending0.20
If hypothesis is true, intervention require extensive safety evaluationrequire extensive safety evaluation— no observation —pending0.20
If hypothesis is true, intervention be combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packaging of mitochobe combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packaging of mit— no observation —pending0.20
🔮 Falsifiable Predictions (5)
pendingconf 20%
If hypothesis is true, intervention be re-engineered to function in the mammalian cellular environment
Predicted outcome: be re-engineered to function in the mammalian cellular environment
Falsification: Intervention fails to be re-engineered to function in the mammalian cellular environment
pendingconf 20%
If hypothesis is true, intervention require a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniques
Predicted outcome: require a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniques
Falsification: Intervention fails to require a multi-phase experimental approach combining synthetic biology, cell biology, and neuroscience techniques
pendingconf 20%
If hypothesis is true, intervention require extensive optimization
Predicted outcome: require extensive optimization
Falsification: Intervention fails to require extensive optimization
pendingconf 20%
If hypothesis is true, intervention require extensive safety evaluation
Predicted outcome: require extensive safety evaluation
Falsification: Intervention fails to require extensive safety evaluation
pendingconf 20%
If hypothesis is true, intervention be combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packaging of mitochondria for intercellular transfer
Predicted outcome: be combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packag
Falsification: Intervention fails to be combined with mammalian membrane remodeling proteins such as dynamin-related proteins or mitofusins to facilitate the controlled release and packaging of mitochondria for inte
View on SciDEX ↗